$995 Million is the total value of HealthCor Management, L.P.'s 58 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 45.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BSX | Sell | BOSTON SCIENTIFIC CORP | $67,384,000 | -17.8% | 1,807,990 | -2.3% | 6.77% | +23.9% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $61,402,000 | +3.6% | 740,948 | -3.6% | 6.17% | +56.0% |
| CNC | Sell | CENTENE CORP DEL | $45,762,000 | -14.3% | 540,860 | -14.8% | 4.60% | +29.0% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $35,045,000 | -5.3% | 68,230 | -6.0% | 3.52% | +42.6% |
| NTRA | Sell | NATERA INC | $31,840,000 | -46.0% | 898,420 | -38.0% | 3.20% | -18.7% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $31,756,000 | -18.0% | 412,420 | -22.2% | 3.19% | +23.5% |
| LIVN | Sell | LIVANOVA PLC | $30,395,000 | -26.1% | 486,550 | -3.1% | 3.05% | +11.4% |
| ANTM | Sell | ELEVANCE HEALTH INC | $26,170,000 | -27.4% | 54,230 | -26.1% | 2.63% | +9.4% |
| DHR | Sell | DANAHER CORPORATION | $24,561,000 | -14.1% | 96,880 | -0.6% | 2.47% | +29.4% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $22,200,000 | -56.6% | 156,910 | -52.6% | 2.23% | -34.7% |
| HUM | Sell | HUMANA INC | $22,102,000 | -53.4% | 47,220 | -56.7% | 2.22% | -29.8% |
| ABT | Sell | ABBOTT LABS | $21,654,000 | -62.3% | 199,300 | -58.9% | 2.18% | -43.1% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $19,598,000 | -29.4% | 1,418,088 | -0.4% | 1.97% | +6.3% |
| HSIC | Sell | HENRY SCHEIN INC | $19,102,000 | -14.2% | 248,920 | -2.5% | 1.92% | +29.3% |
| CYTK | Sell | CYTOKINETICS INC | $19,079,000 | -54.3% | 485,600 | -57.2% | 1.92% | -31.2% |
| INCY | Sell | INCYTE CORP | $17,787,000 | -55.2% | 234,130 | -53.2% | 1.79% | -32.6% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $17,766,000 | -13.4% | 923,400 | -21.8% | 1.78% | +30.4% |
| BDX | Sell | BECTON DICKINSON & CO | $13,734,000 | -63.5% | 55,710 | -60.6% | 1.38% | -45.0% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $13,499,000 | -59.2% | 134,040 | -41.3% | 1.36% | -38.6% |
| MCK | Sell | MCKESSON CORP | $11,430,000 | -61.0% | 35,040 | -63.4% | 1.15% | -41.3% |
| COO | Sell | COOPER COS INC | $9,635,000 | -78.8% | 30,770 | -71.7% | 0.97% | -68.0% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $3,963,000 | -31.8% | 217,165 | -17.8% | 0.40% | +2.6% |
| QTRX | Sell | QUANTERIX CORP | $3,263,000 | -54.7% | 201,560 | -18.2% | 0.33% | -31.7% |
| IMGN | Sell | IMMUNOGEN INC | $2,250,000 | -63.9% | 500,000 | -61.8% | 0.23% | -45.7% |
| IKNA | Sell | IKENA ONCOLOGY INC | $975,000 | -44.4% | 220,082 | -23.5% | 0.10% | -16.2% |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -217,457 | -100.0% | -0.06% | – | |
| PCRX | Exit | PACIRA BIOSCIENCES INC | $0 | – | -13,930 | -100.0% | -0.07% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -9,170 | -100.0% | -0.10% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -23,480 | -100.0% | -0.15% | – |
| STXS | Exit | STEREOTAXIS INC | $0 | – | -821,850 | -100.0% | -0.20% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -140,630 | -100.0% | -0.25% | – |
| CANO | Exit | CANO HEALTH INC | $0 | – | -711,970 | -100.0% | -0.30% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -9,570 | -100.0% | -0.45% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -200,000 | -100.0% | -0.47% | – |
| SYK | Exit | STRYKER CORPORATION | $0 | – | -43,760 | -100.0% | -0.78% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -48,890 | -100.0% | -0.82% | – |
| PFE | Exit | PFIZER INC | $0 | – | -242,880 | -100.0% | -0.84% | – |
| RACB | Exit | RESEARCH ALLIANCE CORP II | $0 | – | -1,324,800 | -100.0% | -0.86% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -317,280 | -100.0% | -1.20% | – |
| WOOF | Exit | PETCO HEALTH & WELLNESS CO I | $0 | – | -1,215,000 | -100.0% | -1.59% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -108,890 | -100.0% | -1.76% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -286,600 | -100.0% | -1.94% | – |
| TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -99,150 | -100.0% | -2.35% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -254,160 | -100.0% | -2.75% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -914,490 | -100.0% | -2.97% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -600,000 | -100.0% | -3.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.